Mark Sulik, PharmD
Senior Clinical Research Advisor

Mark Sulik, PharmD is the Senior Clinical Research Advisor at Rocky Mountain Clinical Research in Idaho Falls. Rocky Mountain Clinical Research is an endocrine and diabetes clinical research center.

Undergraduate

Utah State University – General Studies
Idaho State University – Pre-Pharmacy

College of Pharmacy:

Idaho State University
Pharm D

Certifications:

Northwestern University – Clinical Research Coordinator Basic Training
Pharmacy Partner in Diabetes Care (PPDC)
Certified Clinical Research Professional (CCRP)

Experiential Expertise:

  • Eli Lilly – Coordinators Advisory Board
  • Eli Lilly – Technology Advisory Board
  • Eli Lilly – Study Coordinator Advisory Board
  • Eli Lilly – Biomedicine Advisory Board
  • Eli Lilly – Study Implementation & ePRO Technology
  • Eli Lilly – Clinical Research Strategy & Study Design

Professional Affiliations:

  • American Diabetes Association
  • Model Agreements & Guidelines International (MAGI)
  • Association of Clinical Research Professionals (ACRP)
  • Society of Clinical Research Associates (SOCRA)

Awards

T1D Exchange:

Residual C-Peptide Study
Outstanding Performance Award
Co-Recipient 2013, 2014, 2015

T1D Exchange:
Severe Hypoglycemia in Oder Adults with T1D
Outstanding Performance Award
Co-Recipient 2015

Mark Sulik, PharmD, is the Senior Clinical Research Advisor for Rocky Mountain Clinical Research. Mark maintains robust communication and information exchange between the clinical trial investigators and the research teams at Rocky Mountain Clinical Research.

After Graduating from the pharmacy program at Idaho State University in 1999, Mark worked as a clinical and out-patient pharmacist for Pocatello Regional Medical Center. He then worked as a consulting pharmacist for 12 nursing homes in Southern Idaho. Mark then took a position working at Rite Aid as a pharmacist, where he worked for nearly six years before joining Rocky Mountain Clinical Research. During his time at Rite Aid, Mark was selected to be one of the pharmacists to complete the Pharmacy Partners in Diabetes Care Program, which included extensive education and training in the treatment of diabetes and associated complications.

During his time at Rocky Mountain Clinical Research as the Research Director, Mark established detailed record keeping and precise implementation of a variety of clinical research projects for many of the leading pharmaceutical companies. With the strict standards and regulatory requirements of the FDA and other agencies, Mark implemented strict standard operating procedures (SOPs), an extensive quality assurance (QA) program, and comprehensive training programs for all research department personnel. By doing so, he ensured an optimal and efficient clinical research facility that is able to handle the most demanding clinical trials.

Mark also served on several advisory boards for Eli Lilly, helping to make protocol development more efficient. His involvement has helped improve data collection and further the development and improvements of electronic diaries for subject use. Mark’s meticulous work with the entire clinical research staff established the highest caliber of clinical research studies available in the United States and around the world.

Mark’s greatest joy is helping people who want to succeed and improve their health and lifestyle. He continually strives to find ways to make the research process more efficient and more enjoyable for all involved.

Personal Background

Mark was born in Pocatello, Idaho and graduated from Soda Springs High School where he was an accomplished trombone player.

He married his best friend after serving a two-year church mission in Frankfurt Germany.

Mark likes to cook, eat, and play racquetball. He also enjoys a round of golf when he gets a chance.